Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
Evaluate the pharmacokinetics (PK), Safety and tolerability of guaifenesin (Mucinex®) in an
immediate-release formulation when a single dose is administered in adolescents and in adults
when compared to Children.
Phase:
Phase 1
Details
Lead Sponsor:
Reckitt Benckiser LLC
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Guaifenesin Phenylpropanolamine